State of Digital Health.

AI trends.

Surgical robots. 

 

View in browser

April 18, 2026

Hi there, 

 

Here is this week's top research. 

ICYMI
 

State of AI Q1’26 Report

From record funding to massive bets on physical AI, we examine key developments in the AI landscape using CB Insights proprietary data.

SoAI-Q126-TLDRchart4-v3
CB Insights GenAI Signal Tracker

Among emerging genAI startups, visual model developer Black Forest Labs holds the highest Mosaic score of (935/1,000), a signal of private company momentum and its likelihood of success. Track other emerging generative AI startups, shifting markets, and breakout opportunities with our dynamic signal tracker.

Screenshot 2026-04-17 at 11.07.35 AM

State of Venture Q1’26

Quarterly funding hit a record $286B. Exits declined to a two-year low. The global investor market is shrinking. CB Insights data reveals the key shifts reshaping the venture landscape in 2026.

image3-Apr-09-2026-09-00-21-8717-PM
What’s next for AI agent ROI?

Enterprises are struggling to measure the ROI of AI agents, creating demand for infrastructure focused on performance visibility, context management, and cost attribution. Using CB Insights’ predictive signals, we identify the top agent infrastructure markets primed for growth as adoption shifts from experimentation to production.

Screenshot-2026-01-29-at-10.48.53 AM-roundedcorners-1024x900 (1)
State of Digital Health Q1’26

Digital health accelerated into 2026, with funding and deal size both climbing as capital concentrated in fewer, larger bets.

State-of-Digital-Health_Q126_MnA-1-1013x1024

Customer-Exclusive Research

 

Surgical robots reach an inflection point: Here are the M&A targets leading the shift

Using CB Insights' proprietary Mosaic scores and M&A probability signals, we analyzed 40+ surgical robotics companies to surface the 6 best positioned for acquisition.

Surgical-robotics-MA-targets-1-1024x1024 (1)

The pharmaceutical manufacturing value chain market map

We mapped 90+ companies across 17 markets in the pharmaceutical manufacturing value chain and leveraged our predictive signals to identify emerging trends.

PharmaceuticalManufacturing-ValueChain-012026-4-971x1536

 

Have a great weekend.

 

I love you. 

 

Anand

@asanwal

Co-Founder & Exec Chair

 

P.S. Did you miss our briefing on the State of Venture Q1’26? Get the recording here. 

Get started with CB Insights

Start your free trial

CB Insights' emerging technology insights platform provides all the analysis and data from this newsletter. Our data is the easiest way to discover and respond to emerging tech. 

Was this email forwarded to you? Sign up here

X
LinkedIn
CB-Insights-Icon-Light

Copyright © 2026 CB Insights, All rights reserved.

498 7th Avenue, NY, CB Insights, New York,10018

About Us | Update Preferences | Research | Newsletter